狄戈辛片(0.25mg)和洋地黄毒甙片(0.1mg),由于其治疗量与中毒量接近,每片含主药量甚微,因此考查各片之间的均匀性,对保证临床用药的安全、有效具有重要意义。对其含量均匀度的检查,国外药典均有收载,用荧光分光法测定狄戈辛片的溶出度,国内也已有报道。我们参照英国药典的荧光分光法,进行了含量均匀度考查,并提出了该两品种的判断标准。 Digoxin tablets (0.25mg) and digoxigenin tablets (0.1mg), due to its treatment volume and the amount of poisoning, each containing a small amount of primary drug, so check the uniformity between the pieces, to ensure that clinical medication The safety, effectiveness is of great significance. The examination of its content uniformity, foreign pharmacopoeia have been included, using the spectrofluorimetric determination of digetin dissolution, domestic has also been reported. We refer to the British Pharmacopoeia fluorescence spectroscopy, carried out content uniformity test, and put forward the two varieties of the criteria.